Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul 27;11(15):4351.
doi: 10.3390/jcm11154351.

Neuroendocrine Tumors: Challenges and Future Perspectives

Giuseppe Lamberti  1 , Anna La Salvia  2
Affiliations
Editorial

Neuroendocrine Tumors: Challenges and Future Perspectives

Giuseppe Lamberti et al. J Clin Med. .

Abstract

The awareness and interest of the scientific community towards Neuroendocrine tumors (NETs) has progressively increased in the last few decades [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Dasari A., Shen C., Halperin D., Zhao B., Zhou S., Xu Y., Shih T., Yao J.C. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients with Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3:1335. doi: 10.1001/jamaoncol.2017.0589. - DOI - PMC - PubMed
    1. Yao J.C., Hassan M., Phan A., Dagohoy C., Leary C., Mares J.E., Abdalla E.K., Fleming J.B., Vauthey J.N., Rashid A., et al. One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 2008;26:3063–3072. doi: 10.1200/JCO.2007.15.4377. - DOI - PubMed
    1. Garcia-Carbonero R., Capdevila J., Crespo-Herrero G., Diaz-Perez J.A., Del Prado M.M., Orduña V.A., Sevilla-García I., Villabona-Artero C., Beguiristain-Gómez A., Llanos-Muñoz M., et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE) Ann. Oncol. 2010;21:1794–1803. doi: 10.1093/annonc/mdq022. - DOI - PubMed
    1. Pavel M., Öberg K., Falconi M., Krenning E.P., Sundin A., Perren A., Berruti A. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2020;31:844–860. doi: 10.1016/j.annonc.2020.03.304. - DOI - PubMed
    1. Oberg K., Couvelard A., Delle Fave G., Gross D., Grossman A., Jensen R.T., Pape U.F., Perren A., Rindi G., Ruszniewski P., et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers. Neuroendocrinology. 2017;105:201–211. doi: 10.1159/000472254. - DOI - PubMed

Publication types

LinkOut - more resources